Advertisement

Cardiovascular Disease Risk

Disease State Hub

Featured

FDA Alert
FDA Alert
03/21/2024

Anthony Calabro, MA

Anthony Calabro, MA
On March 8, the FDA approved the injectable weight loss medication, semaglutide, for reducing the risk of cardiovascular events such as heart attack, stroke, and cardiovascular death in adults with heart...
03/21/2024
Commentary
Michael J. Bloch, MD
Commentary
03/05/2024
In this article, Michael J Bloch, MD, discusses the usage of RAS-blocking agents, slowing the progression of end-stage renal disease, and reducing cardiovascular events in patients with advanced kidney...
03/05/2024
Research Summary
Research Summary
02/28/2024

Jessica Ganga

Jessica Ganga
Researchers found that the current recommendations for vitamin D intake in individuals are not enough for patients to reach optimal vitamin D levels.
02/28/2024
Advertisement

Interactive Features

Disease Risk
Sugar on a spoon.
Disease Risk
11/15/2022
Your patient is a 29-year-old woman who drinks four cups of coffee per day, and adds sweetener to each cup. She asks you if drinking black coffee would be healthier and if sweetener is detrimental to her...
11/15/2022
Cardiovascular Health
Cardiovascular Health
08/23/2022
At a recent check-up, your 28-year-old patient says she noticed a difference in their overall health since restaurants reopened after the COVID-19 lockdown in the last couple of years. She tells you she has...
08/23/2022
Cardiovascular Risk
Cardiovascular Risk
09/17/2021
The American Heart Association has identified 7 key risk factors that patients can improve through lifestyle changes to help achieve ideal cardiovascular (CV) health. Print out this sheet of Life's...
09/17/2021
Nutrition
Nutrition
04/08/2020
Intake of healthy fats is recommended to lower cardiovascular risk. Do you know whether the intake of trans fats is recommended?
04/08/2020
Aspirin
Aspirin
03/05/2020
Recently, aspirin use for the prevention of cardiovascular disease has been controversial. Do you know what the ACC/AHA recommend?
03/05/2020

Clinical Insights

Commentary
Michael J. Bloch, MD
Commentary
03/05/2024
In this article, Michael J Bloch, MD, discusses the usage of RAS-blocking agents, slowing the progression of end-stage renal disease, and reducing cardiovascular events in patients with advanced kidney...
03/05/2024
Video
Video
02/25/2024

Michael J. Bloch, MD

Michael J. Bloch, MD
In this video, Michael J. Bloch, MD, reviews and discusses a recently published study on the association of menstrual cycle regularity and length with cardiovascular diseases, including how the results...
02/25/2024
Commentary
Commentary
02/09/2024

Michael Bloch, MD; Evan Bloch 

Michael Bloch, MD; Evan Bloch 
In this article, Michael Bloch, MD, and Evan Bloch discuss findings from the SELECT trial, including the use of the glucagon-like peptide 1 receptor agonist, semaglutide, to reduce the risk of major...
02/09/2024
Video
Video
02/08/2024

Michael J. Bloch, MD

Michael J. Bloch, MD
In this video, Michael J. Bloch, MD, discusses cardiovascular disease in women, including a woman's premenopausal life and its impact on cardiovascular disease risk post-menopausally and the management of...
02/08/2024
Expert Q&A
Expert Q&A
12/09/2023
Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
12/09/2023